Home > Compound List > Product Information
MDL 72527_Molecular_structure_CAS_93565-01-6)
Click picture or here to close

MDL 72527

Catalog No. M2949 Name Sigma Aldrich
CAS Number 93565-01-6 Website http://www.sigmaaldrich.com
M. F. C12H22Cl2N2 Telephone 1-800-521-8956
M. W. 265.22248 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 154886

SYNONYMS

IUPAC name
(buta-2,3-dien-1-yl)({4-[(buta-2,3-dien-1-yl)amino]butyl})amine dihydrochloride
IUPAC Traditional name
buta-2,3-dien-1-yl[4-(buta-2,3-dien-1-ylamino)butyl]amine dihydrochloride
Synonyms
N1,N4-Bis(2,3-butadienyl)-1,4-butanediamine hydrochloride
MDL-72527DA
N,N′-Bis(2,3-butadienyl)-1,4-butanediamine dihydrochloride
CPC-200

DATABASE IDS

MDL Number MFCD13152261
CAS Number 93565-01-6

PROPERTIES

Empirical Formula (Hill Notation) C12 H20 N2·2 HCl
Purity ≥98% (HPLC)
Apperance light yellow to light brown powder
Solubility DMSO: ≥20 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26
Storage Temperature room temp
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
MDL 72527is an inhibitor of polyamine oxidase (spermine oxidase SMO). It blocks the production of H2O2 and increases the cells survival. Polyamine catabolism is one of the major causes of the ROS production of prostate cells in general and androgen-induced enhancement of ROS in androgen-dependent CaP cells in particular. Reports suggest that androgen stimulation of prostate cancer results in accumulation of ROS, which lead to progression of cancer, such progression is control by MDL 72527.
Description (简体中文)
Biochem/physiol Actions
MDL 72527is an inhibitor of polyamine oxidase (spermine oxidase SMO). It blocks the production of H2O2 and increases the cells survival. Polyamine catabolism is one of the major causes of the ROS production of prostate cells in general and androgen-induced enhancement of ROS in androgen-dependent CaP cells in particular. Reports suggest that androgen stimulation of prostate cancer results in accumulation of ROS, which lead to progression of cancer, such progression is control by MDL 72527.

REFERENCES